UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 118 filers reported holding COHERUS BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2023$452,227
-11.0%
135,8040.0%0.00%
Q3 2023$507,906
-34.8%
135,804
+19.3%
0.00%
Q2 2023$778,9380.0%113,8800.0%0.00%
Q1 2023$778,938
-6.3%
113,880
+8.5%
0.00%
Q4 2022$831,395
-99.8%
104,974
+85.8%
0.00%
Q3 2022$542,982,000
+19.3%
56,502
-10.1%
0.00%
Q2 2022$455,243,000
-55.3%
62,879
-20.3%
0.00%
Q1 2022$1,018,741,000
-19.1%
78,9110.0%0.00%
Q4 2021$1,259,421,000
-0.7%
78,9110.0%0.00%
-100.0%
Q3 2021$1,268,099,000
+16.2%
78,9110.0%0.00%
Q2 2021$1,091,339,000
-64.7%
78,911
-62.7%
0.00%
-100.0%
Q1 2021$3,089,268,000
-92.1%
211,449
-90.6%
0.00%
-94.4%
Q4 2020$39,172,887,000
+25.8%
2,253,906
+32.7%
0.02%
+5.9%
Q3 2020$31,147,224,000
-5.1%
1,698,322
-7.6%
0.02%
-15.0%
Q2 2020$32,811,677,000
+8.8%
1,837,160
-1.2%
0.02%
-9.1%
Q1 2020$30,155,853,000
-12.7%
1,859,177
-3.0%
0.02%
+4.8%
Q4 2019$34,524,120,000
+8.5%
1,917,474
+22.1%
0.02%0.0%
Q3 2019$31,817,945,000
-5.2%
1,570,481
+3.4%
0.02%
-12.5%
Q2 2019$33,559,139,000
+56.5%
1,518,513
-3.4%
0.02%
+50.0%
Q1 2019$21,440,580,000
+80.2%
1,571,890
+19.6%
0.02%
+60.0%
Q4 2018$11,898,027,000
-42.9%
1,314,699
+4.2%
0.01%
-33.3%
Q3 2018$20,820,313,000
+13.3%
1,261,837
-3.9%
0.02%
+7.1%
Q2 2018$18,381,622,000
+25.9%
1,312,973
-0.6%
0.01%
+16.7%
Q1 2018$14,600,034,000
+19.0%
1,321,270
-5.2%
0.01%
+20.0%
Q4 2017$12,264,217,000
-30.5%
1,393,661
+5.5%
0.01%
-37.5%
Q3 2017$17,634,697,000
-11.7%
1,320,951
-5.1%
0.02%
-15.8%
Q2 2017$19,963,950,000
+4.8%
1,391,216
+54.5%
0.02%0.0%
Q1 2017$19,041,706,000
+134746.7%
900,317
+79.5%
0.02%
+18.8%
Q4 2016$14,121,000
+2701.8%
501,673
+2562.1%
0.02%
+1500.0%
Q3 2016$504,000
+148.3%
18,845
+97.0%
0.00%
Q1 2016$203,000
-23.1%
9,567
-16.8%
0.00%
Q4 2015$264,00011,4990.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q2 2018
NameSharesValueWeighting ↓
CM Management, LLC 1,100,000$1,903,0001.75%
AlphaCentric Advisors LLC 1,000,000$1,730,0001.27%
Tejara Capital Ltd 1,030,386$1,782,5680.65%
Rubric Capital Management LP 10,400,000$17,992,0000.47%
Birchview Capital, LP 270,000$467,1000.43%
TANG CAPITAL MANAGEMENT LLC 1,050,000$1,816,5000.18%
Bridge City Capital, LLC 316,009$546,6960.18%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$5,252,4130.16%
Tyche Wealth Partners LLC 215,902$373,5100.09%
Pennant Investors, LP 168,100$290,8130.08%
View complete list of COHERUS BIOSCIENCES INC shareholders